Ascentage Pharma Group International
AAPG
View Detailed Chart
26.980USD
-0.900-3.23%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-3.23%
5 Days
-8.35%
1 Month
-11.95%
6 Months
-27.38%
Year to Date
0.00%
1 Year
0.00%
View Detailed Chart
TradingKey Stock Score
No stock score available due to insufficient data.
Ascentage Pharma Group International News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Ascentage Pharma Group International Info
Ascentage Pharma Group International is an investment holding company primarily engaged in the discovery, development, and commercialization of therapies for hematologic malignancies. The Company's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The Company's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), and multiple myeloma (MM). The Company primarily conducts its businesses in domestic market.
Ticker SymbolAAPG
CompanyAscentage Pharma Group International
CEOYang (Dajun)
Websitehttps://www.ascentage.cn/
FAQs
What is the current price of Ascentage Pharma Group International (AAPG)?
The current price of Ascentage Pharma Group International (AAPG) is 26.980.
What is the symbol of Ascentage Pharma Group International?
The ticker symbol of Ascentage Pharma Group International is AAPG.
What is the 52-week high of Ascentage Pharma Group International?
The 52-week high of Ascentage Pharma Group International is 48.450.
What is the 52-week low of Ascentage Pharma Group International?
The 52-week low of Ascentage Pharma Group International is 16.500.
What is the market capitalization of Ascentage Pharma Group International?
The market capitalization of Ascentage Pharma Group International is --.
What is the net income of Ascentage Pharma Group International?
The net income of Ascentage Pharma Group International is --.
Is Ascentage Pharma Group International (AAPG) currently rated as Buy, Hold, or Sell?
According to analysts, Ascentage Pharma Group International (AAPG) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Ascentage Pharma Group International (AAPG)?
The Earnings Per Share (EPS TTM) of Ascentage Pharma Group International (AAPG) is --.
Popular Symbols
